| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Receptos Inc | 28,124 | 5,345,000 | 4.23% | ||
| 2 | SEATTLE GENETICS INC | 104,339 | 5,050,000 | 4.00% | ||
| 3 | BIOMARIN | 35,899 | 4,910,000 | 3.89% | ||
| 4 | PROSHARES TR | 53,568 | 4,842,000 | 3.83% | ||
| 5 | ILLUMINA INC | 21,451 | 4,684,000 | 3.71% | ||
| 6 | CLOVIS ONCOLOGY INC | 52,400 | 4,605,000 | 3.65% | ||
| 7 | NEKTAR THERAPEUTICS COM | 367,963 | 4,603,000 | 3.65% | ||
| 8 | ALKERMES PLC SHS | 71,022 | 4,570,000 | 3.62% | ||
| 9 | BIOGEN INC | 11,254 | 4,546,000 | 3.60% | ||
| 10 | REGENERON PHARMACEUTICALS | 8,759 | 4,468,000 | 3.54% | ||
| 11 | CELGENE CORP | 38,375 | 4,441,000 | 3.52% | ||
| 12 | INCYTE | 41,873 | 4,364,000 | 3.46% | ||
| 13 | VERTEX PHARMACEUT | 35,276 | 4,356,000 | 3.45% | ||
| 14 | ALNYLAM PHARMACEUTICALS INC | 34,979 | 4,193,000 | 3.32% | ||
| 15 | MEDIVATION INC | 34,344 | 3,922,000 | 3.11% | ||
| 16 | CEPHEID | 63,635 | 3,891,000 | 3.08% | ||
| 17 | ALEXION PHARMACEUTIC | 21,474 | 3,882,000 | 3.07% | ||
| 18 | IONIS PHARMACEUTICAL | 66,208 | 3,810,000 | 3.02% | ||
| 19 | METTLER-TOLEDO | 11,000 | 3,756,000 | 2.97% | ||
| 20 | QIAGEN NV | 140,000 | 3,471,000 | 2.75% | ||
| 21 | BIO TECHNE CORP | 34,000 | 3,348,000 | 2.65% | ||
| 22 | PACIRA BIOSCIENCES INC | 47,000 | 3,324,000 | 2.63% | ||
| 23 | ASTRAZENECA PLC | 50,000 | 3,186,000 | 2.52% | ||
| 24 | ARRAY BIOPHARMA INC COM | 320,000 | 2,307,000 | 1.83% | ||
| 25 | HOLOGIC INC | 48,000 | 1,827,000 | 1.45% | ||
| 26 | TESARO INC | 30,000 | 1,764,000 | 1.40% | ||
| 27 | EPIZYME INC COM | 72,379 | 1,737,000 | 1.38% | ||
| 28 | SPDR SER TR | 1,000 | 1,350,000 | 1.07% | Put | |
| 29 | VERICEL CORP | 362,157 | 1,293,000 | 1.02% | ||
| 30 | ASSEMBLY BIOSCIENCES INC | 65,000 | 1,252,000 | 0.99% | ||
| 31 | Esperion Therapeutics Inc | 15,000 | 1,226,000 | 0.97% | ||
| 32 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 51,788 | 1,097,000 | 0.87% | ||
| 33 | UNITED THERAPEUTICS | 5,399 | 939,000 | 0.74% | ||
| 34 | NANOSTRING TECHNOLOGIES INC | 60,000 | 925,000 | 0.73% | ||
| 35 | ULTRAGENYX PHARMACEUTICAL INC COM | 9,000 | 922,000 | 0.73% | ||
| 36 | SANOFI SPOND FUNSPONSORED ADR | 72,009 | 890,000 | 0.70% | ||
| 37 | CHIMERIX INC | 19,152 | 885,000 | 0.70% | ||
| 38 | STEMLINE THERAPEUTICS INC | 75,000 | 883,000 | 0.70% | ||
| 39 | INFINITY PHARMACEUTICALS INC COM | 80,000 | 876,000 | 0.69% | ||
| 40 | AMGEN INC | 5,550 | 852,000 | 0.67% | ||
| 41 | XENOPORT INC | 130,000 | 797,000 | 0.63% | ||
| 42 | Curis, Inc | 215,000 | 712,000 | 0.56% | ||
| 43 | OCERA THERAPEUTICS INC | 186,573 | 709,000 | 0.56% | ||
| 44 | BIODEL INC | 650,000 | 670,000 | 0.53% | ||
| 45 | RELYPSA INC | 18,000 | 596,000 | 0.47% | ||
| 46 | ACHILLION PHARMACEUTICALS INC COM | 66,704 | 591,000 | 0.47% | ||
| 47 | Arrowhead Pharma Inc | 82,133 | 587,000 | 0.46% | ||
| 48 | ZOGENIX INC | 300,000 | 504,000 | 0.40% | ||
| 49 | GILEAD SCIENCES INC | 4,234 | 496,000 | 0.39% | ||
| 50 | REPROS THERAPEUTICS INC | 98,000 | 456,000 | 0.36% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001387131-15-002533, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
